145 related articles for article (PubMed ID: 6183335)
21. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
22. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
23. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
[TBL] [Abstract][Full Text] [Related]
24. Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity.
Ortaldo JR; Phillips W; Wasserman K; Herberman RB
J Immunol; 1980 Oct; 125(4):1839-44. PubMed ID: 6157747
[TBL] [Abstract][Full Text] [Related]
25. Identification and separation by bacterial adherence of human lymphocytes that suppress natural cytotoxicity.
DeBoer KP; Kleinman R; Teodorescu M
J Immunol; 1981 Jan; 126(1):276-81. PubMed ID: 6969743
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis.
Santoli D; Hall W; Kastrukoff L; Lisak RP; Perussia B; Trinchieri G; Koprowski H
J Immunol; 1981 Apr; 126(4):1274-8. PubMed ID: 6162885
[TBL] [Abstract][Full Text] [Related]
27. Regulation of human cytotoxic lymphocyte responses. II. Suppression by a soluble factor produced by primed lymphocytes.
Crosier PS; Broom BC
Immunology; 1981 May; 43(1):19-24. PubMed ID: 6454647
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
29. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
Trinchieri G; O'Brien T; Shade M; Perussia B
J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
[TBL] [Abstract][Full Text] [Related]
30. NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells.
Brieva JA; Targan S; Stevens RH
J Immunol; 1984 Feb; 132(2):611-5. PubMed ID: 6228592
[TBL] [Abstract][Full Text] [Related]
31. Studies of natural killer cells in pregnancy. II. The immunoregulatory effect of pregnancy substances.
Toder V; Nebel L; Elrad H; Blank M; Durdana A; Gleicher N
J Clin Lab Immunol; 1984 Jul; 14(3):129-33. PubMed ID: 6481789
[TBL] [Abstract][Full Text] [Related]
32. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
33. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor-bearing lymphocytes.
Neville ME
J Immunol; 1980 Dec; 125(6):2604-9. PubMed ID: 6776195
[TBL] [Abstract][Full Text] [Related]
34. Antibody-dependent cellular cytotoxicity effector cell capability among normal individuals.
Edwards DL; Avis FP
J Immunol; 1979 Oct; 123(4):1887-93. PubMed ID: 479605
[TBL] [Abstract][Full Text] [Related]
35. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.
Horwitz DA; Bakke AC; Abo W; Nishiya K
J Immunol; 1984 May; 132(5):2370-4. PubMed ID: 6201542
[TBL] [Abstract][Full Text] [Related]
36. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
[TBL] [Abstract][Full Text] [Related]
37. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
38. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
39. Sea star factor blocks development of T-dependent antibody secreting clones by preventing lymphokine secretion.
Kerlin RL; Cebra JJ; Weinstein PD; Prendergast RA
Cell Immunol; 1994 Jun; 156(1):62-76. PubMed ID: 8200043
[TBL] [Abstract][Full Text] [Related]
40. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
